myf5
has
22
expression phenotype(s)
Page:
1
2
3
???pagination.result.next???
Images
Sources
Experiment + Assay
Phenotypes
Human Diseases
Fig. 5b_c3, d
Sempou E et al. (2022)
Xtr Wt + cacna1c CRISPR + kcnh6 MO
NF10 (in situ hybridization)
Anatomical Phenotype
abnormal gastrulation
Expression Phenotype
absent
myf5
expression in ventral marginal zone
Fig. 5b_c2, d
Sempou E et al. (2022)
Xtr Wt + kcnh6 MO
NF10 (in situ hybridization)
Expression Phenotype
absent
myf5
expression in ventral marginal zone
decreased amount
myf5
expression in dorso-lateral marginal zone
Fig. S4. a_c1,b c_c1,d
Sempou E et al. (2022)
Xtr Wt + kcnh6 MO
NF10 (in situ hybridization)
Anatomical Phenotype
absent paraxial mesoderm
Expression Phenotype
absent
myf5
expression in ventral marginal zone
decreased amount
tbxt
expression in marginal zone
Fig 2 H-J
Kreis J et al. (2022)
Xla Wt + rab7a MO
NF10-11 (in situ hybridization)
Expression Phenotype
decreased amount
myf5.L
expression in dorso-lateral marginal zone
decreased amount
myf5.L
expression in presomitic mesoderm
Fig. 4 H K Q R T
Kreis J et al. (2021)
Xla Wt + rab7a MO
NF10-11.5 (in situ hybridization)
Expression Phenotype
absent
myf5.L
expression in dorsal marginal zone
decreased amount
foxj1.L
expression in dorsal marginal zone
decreased amount
myod1.L
expression in ventro-lateral marginal zone
decreased amount
tbxt.L
expression in dorsal marginal zone
mislocalised
nodal3.1.L
expression in dorsal marginal zone
Fig. 7 KM OQ
Kreis J et al. (2021)
Xla Wt + rab7a MO
NF10-11.5 (in situ hybridization)
Expression Phenotype
absent
myf5.L
expression in dorso-lateral marginal zone
decreased amount
myod1.L
expression in dorso-lateral marginal zone
Fig.4.B,C
Ossipova O et al. (2020)
Xla Wt + pnhd-FLAG + animal cap explant
NF11 (RNA-Seq)
Expression Phenotype
increased amount
myf5.L
expression in the animal cap
decreased amount
ccne2.S
expression in the animal cap
decreased amount
foxi4.2.L
expression in the animal cap
decreased amount
nedd9.L
expression in the animal cap
decreased amount
nedd9.S
expression in the animal cap
decreased amount
xepsin.L
expression in the animal cap
increased amount
cdx1.L
expression in the animal cap
increased amount
cdx4.L
expression in the animal cap
increased amount
esr-5.L
expression in the animal cap
increased amount
flrt3.L
expression in the animal cap
increased amount
hoxd1.L
expression in the animal cap
increased amount
msgn1.L
expression in the animal cap
increased amount
tbxt.S
expression in the animal cap
increased amount
vegt.L
expression in the animal cap
increased amount
wnt8a.L
expression in the animal cap
increased amount
fgf8.L
expression in animal cap
Fig. 9 b-l
Shang N et al. (2020)
Xla.wt + dab2 MO
NF31
Expression Phenotype
decreased amount
myf5.L
expression in dermomyotome
decreased amount
myf5.L
expression in hyoid arch
decreased amount
myf5.L
expression in hypaxial muscle
decreased amount
actn4.L
expression in myotome
decreased amount
mef2c.L
expression in myotome
decreased amount
myod1.L
expression in myotome
decreased amount
myos.L
expression in myotome
decreased amount
pax3.L
expression in hypaxial muscle
decreased amount
pax3.L
expression in myotome
Fig. 5 E
Sempou E et al. (2018)
Xtr Wt + fgfr4 CRISPR
NF10 (in situ hybridization)
Expression Phenotype
decreased amount
myf5
expression in mesoderm
visceral heterotaxy
congenital heart disease
Fig. 5 H
Sempou E et al. (2018)
Xtr Wt + fgfr4 CRISPR
NF12 (in situ hybridization)
Expression Phenotype
decreased amount
myf5
expression in presumptive paraxial mesoderm
visceral heterotaxy
congenital heart disease